Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research

Detalhes bibliográficos
Autor(a) principal: Silva, Antônio Guilherme Sousa
Data de Publicação: 2021
Outros Autores: Gonçalves, Lucas Cândido, Silva, Paulo Alex Neves da, Carneiro, Lilian Carla, Sousa, José Arthur Silva e, Ataídes, Fábio Silvestre, Passos, Xisto Sena, Silva, Antonio Márcio Teodoro Cordeiro, Maia, Yara Lúcia Marques
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/18203
Resumo: This study aimed to measure the efficiency of cinnamon in patients with Type 2 Diabetes Mellitus (DM2), comparing fasting plasma glucose averages and lipid profiles with a placebo group through a meta-analysis. Four databases were the source of the research to find the articles used, including: Medline / PubMed, LILACS and NCBI. 11 randomized clinical trials that evaluated cinnamon on glycemic and lipid parameters were included in this study. Meta-analysis was performed with the aid of the STATA® 16.0 software, which determined the difference in glucose means and lipid profiles compared to a placebo group. Cinnamon at concentrations of 250 mg twice a day decreased blood glucose with MD = -0.25 (95%CI = - 0.36 to -0.14; p<0.00001) and in the intervention with 2 g 3 times a day with MD = -5.60 (95%CI = -6.98 to -4.22; p<0.00001). Total cholesterol was significant with 2 g 3 times a day with MD = 0.98 (95%CI = -1.27 to -0.69), followed by LDL-cholesterol MD = 0.64 (95%CI = 0.88 to 0.40; p<0.00001), and HDL-cholesterol with 500 mg 3 times daily with MD = 0.12 (95%CI = 0.05 to 0.19). High-dose supplementation of cinnamon can reduce glucose and lipid profiles in patients with DM2. This supporting treatment can be useful when added to the diet plan of patients with DM2.
id UNIFEI_a00508a31903cf3a471a2053bd0c54d9
oai_identifier_str oai:ojs.pkp.sfu.ca:article/18203
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical researchPerfil lipídico y glucemia en pacientes con diabetes mellitus tratados con canela - Revisión sistemática y metaanálisis con ensayos clínicos aleatorizadosPerfil lipídico e glicemia em portadores de Diabetes Mellitus tratados com Canela – Revisão Sistemática e Meta-análise com pesquisas clínicas randomizadasType 2 diabetes mellitusCinnamonBlood glucoseLipid profiles.Diabetes Mellitus tipo 2CanelaGlucosaPerfiles lipídicos.Diabete Mellitus tipo 2CanelaGlicemiaPerfis lipídicos.This study aimed to measure the efficiency of cinnamon in patients with Type 2 Diabetes Mellitus (DM2), comparing fasting plasma glucose averages and lipid profiles with a placebo group through a meta-analysis. Four databases were the source of the research to find the articles used, including: Medline / PubMed, LILACS and NCBI. 11 randomized clinical trials that evaluated cinnamon on glycemic and lipid parameters were included in this study. Meta-analysis was performed with the aid of the STATA® 16.0 software, which determined the difference in glucose means and lipid profiles compared to a placebo group. Cinnamon at concentrations of 250 mg twice a day decreased blood glucose with MD = -0.25 (95%CI = - 0.36 to -0.14; p<0.00001) and in the intervention with 2 g 3 times a day with MD = -5.60 (95%CI = -6.98 to -4.22; p<0.00001). Total cholesterol was significant with 2 g 3 times a day with MD = 0.98 (95%CI = -1.27 to -0.69), followed by LDL-cholesterol MD = 0.64 (95%CI = 0.88 to 0.40; p<0.00001), and HDL-cholesterol with 500 mg 3 times daily with MD = 0.12 (95%CI = 0.05 to 0.19). High-dose supplementation of cinnamon can reduce glucose and lipid profiles in patients with DM2. This supporting treatment can be useful when added to the diet plan of patients with DM2.Este estudio tuvo como objetivo medir la eficacia de la canela en pacientes con Diabetes Mellitus tipo 2 (DM2), comparando los perfiles medios de glucosa plasmática y lípidos en ayunas con un grupo de placebo a través de un metanálisis. Cuatro bases de datos fueron la fuente de investigación para los hallazgos de los artículos utilizados, incluyendo: Medline / PubMed, LILACS y NCBI. En este estudio se incluyeron 11 ensayos controlados aleatorios que evaluaron la canela en parámetros glucémicos y lipídicos. El metanálisis se realizó con la ayuda del software STATA® 16.0, que determinó la diferencia en los perfiles medios de glucosa y lípidos en comparación con un grupo de placebo. La canela a concentraciones de 250 mg dos veces al día disminuyó la glucosa en sangre con MD = -0,25 (IC del 95% = -0,36 a -0,14; p <0,00001) y en la intervención con 2 g 3 veces al día al día con MD = -5,60 (IC del 95% = -6,98 a -4,22; p<0,00001). El colesterol total fue significativo con 2 g 3 veces al día con MD = 0,98 (IC del 95% = -1,27 a -0,69), seguido de MD de colesterol LDL = 0,64 (IC del 95% = 0,88 a 0,40; p <0,00001), y Colesterol HDL con 500 mg 3 veces al día con MD = 0,12 (IC del 95% = 0,05 a 0,19). La suplementación con altas dosis de canela puede reducir los perfiles de glucosa y lípidos en sangre en pacientes con DM2. Este puede ser un tratamiento coadyuvante útil cuando se agrega al plan de alimentación de los pacientes con DM2.Esse presente estudo teve como finalidade mensurar a eficiência da canela em portadores de Diabetes Mellitus tipo 2 (DM2), comparando as médias de glicose no plasma em jejum e os perfis lipídicos com um grupo placebo através de uma Metanálise. Quatro bancos de dados foram fonte das pesquisas para achados dos artigos utilizados, incluindo: Medline/PubMed, LILACS e NCBI. 11 ensaios clínicos randomizados que avaliaram a canela nos parâmetros glicêmicos e lipídicos, foram incluídos nesse estudo. A Metanálise foi realizada com o auxílio do software STATA® 16.0, que determinou a diferença das médias de glicose e perfis lipídicos comparando com um grupo placebo. A canela nas concentrações de 250 mg 2 vezes ao dia diminuiu a glicemia com MD= -0,25 (IC95% = - 0,36 a -0,14; p<0,00001) e na intervenção com 2 g 3 vezes ao dia com MD= -5,60 (IC95% = -6,98 a -4,22; p<0,00001). Colesterol total obteve significância com 2 g 3 vezes ao dia com MD = 0,98 (IC95% = -1,27 a -0,69), seguido do LDL-colesterol MD = 0,64 (IC95% = 0,88 a 0,40; p<0,00001), e HDL-colesterol com 500 mg 3 vezes ao dia com MD = 0,12 (IC95% = 0,05 a 0,19). A suplementação com altas doses de canela pode reduzir a glicemia e os perfis lipídicos em pacientes com DM2. Esse pode ser um tratamento coadjuvante útil quando adicionado ao plano alimentar de pacientes com DM2.Research, Society and Development2021-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1820310.33448/rsd-v10i9.18203Research, Society and Development; Vol. 10 No. 9; e45910918203Research, Society and Development; Vol. 10 Núm. 9; e45910918203Research, Society and Development; v. 10 n. 9; e459109182032525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/18203/16355Copyright (c) 2021 Antônio Guilherme Sousa Silva; Lucas Cândido Gonçalves; Paulo Alex Neves da Silva; Lilian Carla Carneiro; José Arthur Silva e Sousa; Fábio Silvestre Ataídes; Xisto Sena Passos; Antonio Márcio Teodoro Cordeiro Silva; Yara Lúcia Marques Maiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Antônio Guilherme SousaGonçalves, Lucas CândidoSilva, Paulo Alex Neves daCarneiro, Lilian CarlaSousa, José Arthur Silva eAtaídes, Fábio SilvestrePassos, Xisto SenaSilva, Antonio Márcio Teodoro CordeiroMaia, Yara Lúcia Marques2021-09-12T14:28:06Zoai:ojs.pkp.sfu.ca:article/18203Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:23.219388Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
Perfil lipídico y glucemia en pacientes con diabetes mellitus tratados con canela - Revisión sistemática y metaanálisis con ensayos clínicos aleatorizados
Perfil lipídico e glicemia em portadores de Diabetes Mellitus tratados com Canela – Revisão Sistemática e Meta-análise com pesquisas clínicas randomizadas
title Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
spellingShingle Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
Silva, Antônio Guilherme Sousa
Type 2 diabetes mellitus
Cinnamon
Blood glucose
Lipid profiles.
Diabetes Mellitus tipo 2
Canela
Glucosa
Perfiles lipídicos.
Diabete Mellitus tipo 2
Canela
Glicemia
Perfis lipídicos.
title_short Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
title_full Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
title_fullStr Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
title_full_unstemmed Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
title_sort Lipid profile and blood glucose in patients with Diabetes Mellitus treated with Cinnamon - Systematic Review and Meta-analysis with randomized clinical research
author Silva, Antônio Guilherme Sousa
author_facet Silva, Antônio Guilherme Sousa
Gonçalves, Lucas Cândido
Silva, Paulo Alex Neves da
Carneiro, Lilian Carla
Sousa, José Arthur Silva e
Ataídes, Fábio Silvestre
Passos, Xisto Sena
Silva, Antonio Márcio Teodoro Cordeiro
Maia, Yara Lúcia Marques
author_role author
author2 Gonçalves, Lucas Cândido
Silva, Paulo Alex Neves da
Carneiro, Lilian Carla
Sousa, José Arthur Silva e
Ataídes, Fábio Silvestre
Passos, Xisto Sena
Silva, Antonio Márcio Teodoro Cordeiro
Maia, Yara Lúcia Marques
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva, Antônio Guilherme Sousa
Gonçalves, Lucas Cândido
Silva, Paulo Alex Neves da
Carneiro, Lilian Carla
Sousa, José Arthur Silva e
Ataídes, Fábio Silvestre
Passos, Xisto Sena
Silva, Antonio Márcio Teodoro Cordeiro
Maia, Yara Lúcia Marques
dc.subject.por.fl_str_mv Type 2 diabetes mellitus
Cinnamon
Blood glucose
Lipid profiles.
Diabetes Mellitus tipo 2
Canela
Glucosa
Perfiles lipídicos.
Diabete Mellitus tipo 2
Canela
Glicemia
Perfis lipídicos.
topic Type 2 diabetes mellitus
Cinnamon
Blood glucose
Lipid profiles.
Diabetes Mellitus tipo 2
Canela
Glucosa
Perfiles lipídicos.
Diabete Mellitus tipo 2
Canela
Glicemia
Perfis lipídicos.
description This study aimed to measure the efficiency of cinnamon in patients with Type 2 Diabetes Mellitus (DM2), comparing fasting plasma glucose averages and lipid profiles with a placebo group through a meta-analysis. Four databases were the source of the research to find the articles used, including: Medline / PubMed, LILACS and NCBI. 11 randomized clinical trials that evaluated cinnamon on glycemic and lipid parameters were included in this study. Meta-analysis was performed with the aid of the STATA® 16.0 software, which determined the difference in glucose means and lipid profiles compared to a placebo group. Cinnamon at concentrations of 250 mg twice a day decreased blood glucose with MD = -0.25 (95%CI = - 0.36 to -0.14; p<0.00001) and in the intervention with 2 g 3 times a day with MD = -5.60 (95%CI = -6.98 to -4.22; p<0.00001). Total cholesterol was significant with 2 g 3 times a day with MD = 0.98 (95%CI = -1.27 to -0.69), followed by LDL-cholesterol MD = 0.64 (95%CI = 0.88 to 0.40; p<0.00001), and HDL-cholesterol with 500 mg 3 times daily with MD = 0.12 (95%CI = 0.05 to 0.19). High-dose supplementation of cinnamon can reduce glucose and lipid profiles in patients with DM2. This supporting treatment can be useful when added to the diet plan of patients with DM2.
publishDate 2021
dc.date.none.fl_str_mv 2021-07-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/18203
10.33448/rsd-v10i9.18203
url https://rsdjournal.org/index.php/rsd/article/view/18203
identifier_str_mv 10.33448/rsd-v10i9.18203
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/18203/16355
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 9; e45910918203
Research, Society and Development; Vol. 10 Núm. 9; e45910918203
Research, Society and Development; v. 10 n. 9; e45910918203
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052684541362176